LorzadehS, GhavamiS. Correspondence on ‘Role of AMPK/mTORindependent autophagy in clear cell renal cell carcinoma’ by Radovanovic et al. J Investig Med2021;69:1483–4.doi:10.1136/jim-2021-002015
2.
RadovanovicM, VidicevicS, TasicJ, . Role of AMPK/mTOR-independent autophagy in clear cell renal cell carcinoma. J Investig Med2020;68:1386–93.doi:10.1136/jim-2020-001524http://www.ncbi.nlm.nih.gov/pubmed/33087428
LópezJI, AnguloJC. Pathological bases and clinical impact of intratumor heterogeneity in clear cell renal cell carcinoma. Curr Urol Rep2018;19:3. doi:10.1007/s11934-018-0754-7http://www.ncbi.nlm.nih.gov/pubmed/29374850
5.
MassariF, CiccareseC, SantoniM, . Metabolic alterations in renal cell carcinoma. Cancer Treat Rev2015;41:767–76.doi:10.1016/j.ctrv.2015.07.002http://www.ncbi.nlm.nih.gov/pubmed/26169313
6.
FaesS, DemartinesN, DormondO. Mechanistic target of rapamycin inhibitors in renal cell carcinoma: potential, limitations, and perspectives. Front Cell Dev Biol2021;9:636037.doi:10.3389/fcell.2021.636037http://www.ncbi.nlm.nih.gov/pubmed/33791295
7.
MiaoH, QiuF, HuangB, . PKCα replaces AMPK to regulate mitophagy: another PEDF role on ischaemic cardioprotection. J Cell Mol Med2018;22:5732–42.doi:10.1111/jcmm.13849http://www.ncbi.nlm.nih.gov/pubmed/30230261
8.
LiuZ, SinKWT, DingH, . p38β MAPK mediates ULK1-dependent induction of autophagy in skeletal muscle of tumor-bearing mice. Cell Stress2018;2:311–24.doi:10.15698/cst2018.11.163http://www.ncbi.nlm.nih.gov/pubmed/31225455
